Pharmaceutical Indian drugmaker Suven Pharmaceuticals (NSE: SUVENPH), CSIR-Indian Institute of Chemical Technology, Hyderabad, and CSIR-National Institute of Interdisciplinary Science & Technology, Thiruvananthapuram. have entered into an agreement for the process technology transfer and manufacturing of the anti-COVID-19 drugs molnupiravir and 2-DG. 11 June 2021